Combination of bortezomib-based chemotherapy and extracorporeal free light chain removal for treating cast nephropathy in multiple myeloma

NDT Plus

Volumn 1, Issue 2, 2008, Pages 106-108

  Bachmann, Ulrike ^a   Schindler, Ralf ^a   Storr, Markus ^b   Kahl, Andreas ^a   Joerres, Achim ^a   Sturm, Isrid ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Gambro Dialysatoren ^*  (Germany)

Author keywords

Cast nephropathy; Free light chains; Haemodialysis; High cutoff; Myeloma

Indexed keywords

BORTEZOMIB; CREATININE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; UREA;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; FEMALE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY DISEASE; LABORATORY TEST; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEINURIA;

EID: 41749084214     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfm053     Document Type: Article

References (11)

1. Knudsen LM, Hippo E, Hjorth M et al. (The Nordic Myeloma Study Group). Renal function in newly diagnosed multiple myeloma-a demographic study of 1353 patients. Eur J Haematol 1994; 53: 207-212
2. Herrera GA, Joseph L, Gu X et al. Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia. Arch Pathol Lab Med 2004; 128: 875-879
3. Clark WF, Stewart AK, Rock GA et al. Plasma exchange when myeloma presents as acute renal failure: A randomized, controlled trial. Ann Intern Med 2005; 143: 777-784
4. Zuchelli P, Pasquali S, Cagnali L et al. Controlled plasma exchange trial in acute renal failure due to multiple myeloma. Kidney Int 1988; 33: 1175-1180
5. Hutchison CA, Cockwell P, Reid S et al. Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies. J Am Soc Nephrol 2007; 18: 886-895
6. Jagannath S. Bortezomib dosing in relapsed multiple myeloma. Clin Lymphoma Myeloma 2006; 7: 101-102
7. Mateos MV, Hernandez JM; Hernandez MT et al. Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: Results of a multicenter phase 1/2 study. Blood 2006; 108: 2165-2172
8. Morgera S, Haase M, Kuss T et al. Pilot study on the effects of high cutoff hemofiltration on the need-for norepinephrine in septic patients with acute renal failure. Crit Care Med 2006; 34: 2099-2104
9. Morgera S, Slowinski T, Melzer C et al. Renal replacement therapy with high-cutoff hemofilters: Impact of convection and diffusion on cytokine clearances and protein status. Am J Kidney Dis 2004; 43: 444-453
10. Tauro S, Clark FJ, Duncan N et al. Recovery of renal function after autologous stem cell transplantation in myeloma patients withi end-stage renal failure. Bone Marrow Tranqplant 2002; 30: 471-4731
11. Pozzi C, D'Amico M, Fogazzi GB et al. Light chain deposition disease with renal involvement: Clinical characteristics and prognostic factors. Am J Kidney Dis 2003; 42: 1154-1163